ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,757.28
0.41%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. UroGen Pharma Ltd (URGN)

  7. UroGen Pharma Ltd (URGN) Noticias

URGN UroGen Pharma Ltd

13.30
-0.25 (-1.85%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
UroGen Pharma Ltd URGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.25 -1.85% 13.30 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
13.55 13.24 13.84 13.30 13.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/5/202407:00BWUroGen Pharma to Present at the TD Cowen 5th Annual Oncology..
13/5/202407:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202407:01EDGAR2Form 8-K - Current report
13/5/202407:00BWUroGen Pharma Announces Date for ENVISION Data, New..
07/5/202407:00BWUroGen Pharma to Participate at Upcoming Investor..
05/5/202411:20BWNew Real-World Retrospective Analysis Presented at AUA 2024..
04/5/202414:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
04/5/202410:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
03/5/202407:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
17/4/202411:02BWUroGen Announces New Data Presentations at the American..
15/4/202407:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
03/4/202407:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
14/3/202407:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
08/3/202407:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
04/3/202407:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
04/3/202406:00EDGAR2Form 8-K - Current report
01/3/202406:00EDGAR2Form 8-K - Current report
26/2/202407:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
12/2/202416:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
07/2/202415:15EDGAR2Form 8-K - Current report
02/2/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202409:13EDGAR2Form 144 - Report of proposed sale of securities
01/2/202408:53EDGAR2Form 144 - Report of proposed sale of securities
01/2/202407:00BWUroGen Pharma to Participate at Upcoming Investor..
24/1/202407:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
17/1/202415:16EDGAR2Form 8-K - Current report
17/1/202407:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
11/1/202407:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
02/1/202407:04EDGAR2Form 8-K - Current report
08/12/202315:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
14/11/202315:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202307:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
13/11/202307:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
07/11/202307:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
03/10/202307:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
11/9/202315:15EDGAR2Form 8-K - Current report
11/9/202306:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
08/9/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
08/9/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202307:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
05/9/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados